Share this:
Email this page Share this on LinkedIn Share this on Twitter Share with your XING network

Videos


Life sciences innovation: The struggle to retain and attract investorsLife sciences innovation: The struggle to retain and attract investorsJanuary 11, 2012 | Biotech Showcase™ 2012Panelists address ways to overcome funding obstacles for innovative life science programs and their investors.view "executive recap" view     view "full session" view
Molecular diagnostics: A sector of increasing importanceMolecular diagnostics: A sector of increasing importanceJanuary 11, 2012 | Biotech Showcase™ 2012Experienced MDx developers, investors and dealmakers explore challenges and opportunities to be managed.view "executive recap" view     view "full session" view
Getting a drug approved as the FDA Is evolvingGetting a drug approved as the FDA Is evolvingJanuary 11, 2012 | Biotech Showcase™ 2012What to do and how to do it as FDA encourages innovators.view "full session" view
Shifting sands: What will drive the next phase of value for the pharma and biotech industries?Shifting sands: What will drive the next phase of value for the pharma and biotech industries?January 10, 2012 | Biotech Showcase™ 2012How will pharma's shift away from traditional interests affect partnering strategies of emerging biotechs?view "executive recap" view     view "full session" view
Case study of the AstraZeneca/Rigel partnershipCase study of the AstraZeneca/Rigel partnershipJanuary 10, 2012 | Biotech Showcase™ 2012Dealmakers discuss the partnership between AstraZeneca and Rigel.view "full session" view
Alternative financing options for life science companiesAlternative financing options for life science companiesJanuary 10, 2012 | Biotech Showcase™ 2012This workshop focuses on the tools an emerging company can use to finance their development.view "executive recap" view     view "full session" view
The 2nd annual Regenerative Medicine State of the Industry briefingThe 2nd annual Regenerative Medicine State of the Industry briefingJanuary 10, 2012 | Biotech Showcase™ 2012The Alliance for Regenerative Medicine briefs on current trends in cell therapy and regenerative medicine.view "full session" view
Reimbursement: A critical component of valuationReimbursement: A critical component of valuationJanuary 9, 2012 | Biotech Showcase™ 2012This panel discusses ways to maximize payment amounts under evolving CMS standards for more favorable valuation.view "full session" view
Redefining exit options given the current economic climateRedefining exit options given the current economic climateJanuary 9, 2012 | Biotech Showcase™ 2012Liquidity options, proposed risk reduction deal structures and other exit pathways are discussed.view "full session" view
Infectious disease: Fighting the #2 global killerInfectious disease: Fighting the #2 global killerJanuary 9, 2012 | Biotech Showcase™ 2012Biotech companies present promising new approaches against the world's #2 killer.view "executive recap" view     view "full session" view
See more on partnering360® ►
Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2012 EBD Group, Inc.
Biotech Showcase 2012 EBD GroupDemy-Colton